Next-Generation Linker Technology

Hummingbird Bioscience has developed a proprietary, differentiated linker technology that enables next-generation dual-payload conjugates. Our technology is capable of producing stable, developable conjugates across various formats.

• Targeting format agnostic – conjugation possible to antibodies, peptides, fragments and more
• Stable conjugates – designed for manufacturability, hydrophilicity, and non-immunogenicity
• Payload and DAR flexibility – applicable to a broad range of payloads, the linker enables both single and dual payload combinations from low to high DAR